119 related articles for article (PubMed ID: 22901621)
1. Steroids and risk of osteonecrosis in ALL: take a break.
van den Heuvel-Eibrink MM; Pieters R
Lancet Oncol; 2012 Sep; 13(9):855-7. PubMed ID: 22901621
[No Abstract] [Full Text] [Related]
2. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group.
Levien MG
Clin Pediatr (Phila); 2002; 41(1):63-4. PubMed ID: 11866371
[No Abstract] [Full Text] [Related]
3. Osteonecrosis in pediatric patients with acute lymphoblastic leukemia.
Murphy RG; Greenberg ML
Cancer; 1990 Apr; 65(8):1717-21. PubMed ID: 2317754
[TBL] [Abstract][Full Text] [Related]
4. Polymorphism in the PAI-1 (SERPINE1) gene and the risk of osteonecrosis in children with acute lymphoblastic leukemia.
Bond J; Adams S; Richards S; Vora A; Mitchell C; Goulden N
Blood; 2011 Sep; 118(9):2632-3. PubMed ID: 21885611
[No Abstract] [Full Text] [Related]
5. Asparaginase combined with discontinuous dexamethasone improves antileukemic efficacy without increasing osteonecrosis in preclinical models.
Karol SE; Janke LJ; Panetta JC; Ramsey LB; Cai X; Payton MA; Jenkins DA; Evans WE; Relling MV
PLoS One; 2019; 14(5):e0216328. PubMed ID: 31059548
[TBL] [Abstract][Full Text] [Related]
6. British OsteoNEcrosis Study (BONES) protocol: a prospective cohort study to examine the natural history of osteonecrosis in older children, teenagers and young adults with acute lymphoblastic leukaemia and lymphoblastic lymphoma.
Amin N; Kinsey S; Feltbower R; Kraft J; Whitehead E; Velangi M; James B
BMJ Open; 2019 May; 9(5):e027204. PubMed ID: 31122988
[TBL] [Abstract][Full Text] [Related]
7. Prospective study on incidence, risk factors, and long-term outcome of osteonecrosis in pediatric acute lymphoblastic leukemia.
te Winkel ML; Pieters R; Hop WC; de Groot-Kruseman HA; Lequin MH; van der Sluis IM; Bökkerink JP; Leeuw JA; Bruin MC; Egeler RM; Veerman AJ; van den Heuvel-Eibrink MM
J Clin Oncol; 2011 Nov; 29(31):4143-50. PubMed ID: 21947829
[TBL] [Abstract][Full Text] [Related]
8. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group.
Mattano LA; Sather HN; Trigg ME; Nachman JB
J Clin Oncol; 2000 Sep; 18(18):3262-72. PubMed ID: 10986059
[TBL] [Abstract][Full Text] [Related]
9. Avascular necrosis of the right elbow occuring while on UKALL 2003 protocol.
Francis S; Johnson K; Darbyshire P
Eur J Haematol; 2008 Aug; 81(2):164. PubMed ID: 18363872
[No Abstract] [Full Text] [Related]
10. Antileukemic Efficacy of Continuous vs Discontinuous Dexamethasone in Murine Models of Acute Lymphoblastic Leukemia.
Ramsey LB; Janke LJ; Payton MA; Cai X; Paugh SW; Karol SE; Kamdem Kamdem L; Cheng C; Williams RT; Jeha S; Pui CH; Evans WE; Relling MV
PLoS One; 2015; 10(8):e0135134. PubMed ID: 26252865
[TBL] [Abstract][Full Text] [Related]
11. Osteonecrosis in children treated for acute leukemia.
Pediatric Hematology Working Group of the Czech Republic and Collaborators
Med Pediatr Oncol; 1999 Jun; 32(6):474-6. PubMed ID: 10358717
[No Abstract] [Full Text] [Related]
12. Assessment of corticosteroid-induced osteonecrosis in children undergoing chemotherapy for acute lymphoblastic leukemia: a report from the Japanese Childhood Cancer and Leukemia Study Group.
Hyakuna N; Shimomura Y; Watanabe A; Taga T; Kikuta A; Matsushita T; Kogawa K; Kawakami C; Horikoshi Y; Iwai T; Okamoto Y; Tsurusawa M; Asami K;
J Pediatr Hematol Oncol; 2014 Jan; 36(1):22-9. PubMed ID: 24136019
[TBL] [Abstract][Full Text] [Related]
13. Avascular necrosis of bone after adult acute lymphocytic leukemia treatment with methotrexate, vincristine, L-asparaginase, and dexamethasone (MOAD).
Hui L; Wiernik PH
Am J Hematol; 1996 Jul; 52(3):184-8. PubMed ID: 8756084
[TBL] [Abstract][Full Text] [Related]
14. Severe hypertriglyceridemia in a 6-year-old boy with ALL relapse: successfully treated with plasmapheresis.
Winkler B; Kuhn S; Kunzmann S; Ruf K; Wiegering V; Schlegel PG
Klin Padiatr; 2013 Nov; 225(6):364-5. PubMed ID: 24158897
[No Abstract] [Full Text] [Related]
15. Effect of post-consolidation regimen on symptomatic osteonecrosis in three DCOG acute lymphoblastic leukemia protocols.
van Atteveld JE; de Groot-Kruseman HA; Fiocco M; Lequin MH; Neggers SJCMM; Pluijm SMF; van der Sluis IM; Pieters R; van den Heuvel-Eibrink MM
Haematologica; 2021 Apr; 106(4):1198-1201. PubMed ID: 32646890
[No Abstract] [Full Text] [Related]
16. [Development of aseptic osteonecrosis during the treatment of acute lymphoblastic leukemia: review of the literature and author's own data].
Baranova OIu; Shirin AD; Falaleeva NA; Osmanov DSh
Ter Arkh; 2011; 83(7):26-32. PubMed ID: 21894748
[TBL] [Abstract][Full Text] [Related]
17. Osteonecrosis during the treatment of childhood acute lymphoblastic leukemia: a prospective MRI study.
Ojala AE; Pääkkö E; Lanning FP; Lanning M
Med Pediatr Oncol; 1999 Jan; 32(1):11-7. PubMed ID: 9917747
[TBL] [Abstract][Full Text] [Related]
18. Avascular necrosis--an antineoplastic-treatment-related toxicity: the experiences of two institutions.
Sawicka-Zukowska M; Kajdas L; Muszynska-Roslan K; Krawczuk-Rybak M; Sonta-Jakimczyk D; Szczepanski T
Pediatr Hematol Oncol; 2006 Dec; 23(8):625-9. PubMed ID: 17065138
[TBL] [Abstract][Full Text] [Related]
19. [Intrathecal chemotherapy in acute lymphoblastic leukemia. Prospective evaluation of toxicity using a combination employed in Mexico].
Gómez-Almaguer D; Almaguer-Gaona C; Mora-Brondo P; González-Llano O; Marfil-Rivera J; Villarreal G
Rev Invest Clin; 1988; 40(2):129-33. PubMed ID: 3175366
[No Abstract] [Full Text] [Related]
20. Osteonecrosis: An emerging complication of intensive chemotherapy for childhood acute lymphoblastic leukemia.
Aricò M; Boccalatte MF; Silvestri D; Barisone E; Messina C; Chiesa R; Santoro N; Tamaro P; Lippi A; Gallisai D; Basso G; De Rossi G;
Haematologica; 2003 Jul; 88(7):747-53. PubMed ID: 12857552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
